Literature DB >> 6840170

Increased oral clearance of metoprolol in pregnancy.

S Högstedt, B Lindberg, A Rane.   

Abstract

The disposition of oral metoprolol was studied in 5 women during the last trimester of pregnancy and 3 to 5 months after delivery. After a single oral dose of 100 mg the individual peak plasma concentration in the pregnant state was only 20-40% of that after pregnancy. The plasma half-lives of metoprolol were about the same during (average 1.3 h) and after pregnancy (average 1.7 h). By contrast, the area under the plasma concentration versus time curve was much smaller during (mean 262 nmol/1 X h) than after (mean 1298 nmol/1 X h) pregnancy, resulting in an average apparent oral clearance (Clo) of metoprolol that was 4.4 times higher during (362 ml X kg-1 body-weight X min-1) than after pregnancy. The increased Clo in pregnancy is assumed to be due to enhanced hepatic metabolism of the drug. The possible clinical consequence of the difference in the disposition of metoprolol is discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6840170     DOI: 10.1007/bf00613820

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  19 in total

1.  Distribution of salicylate between neonatal and maternal serum at diffusion equilibrium.

Authors:  G Levy; J A Procknal; L K Garrettson
Journal:  Clin Pharmacol Ther       Date:  1975-08       Impact factor: 6.875

2.  Quantitative determination of metoprolol in plasma and urine by gas chromatography.

Authors:  M Ervik
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1975

Review 3.  Drug kinetics in pregnancy.

Authors:  B Krauer; F Krauer
Journal:  Clin Pharmacokinet       Date:  1977 May-Jun       Impact factor: 6.447

4.  Binding of salicylic acid and sulphanilamide in serum from pregnant patients, cord blood and subjects taking oral contraceptives.

Authors:  J S Crawford; H W Hooi
Journal:  Br J Anaesth       Date:  1968-11       Impact factor: 9.166

5.  Gastric emptying time in late pregnancy and labour.

Authors:  J S Davison; M C Davison; D M Hay
Journal:  J Obstet Gynaecol Br Commonw       Date:  1970-01

6.  Antiepileptic drugs: metabolism in pregnancy.

Authors:  M Dam; J Christiansen; O Munck; K I Mygind
Journal:  Clin Pharmacokinet       Date:  1979 Jan-Feb       Impact factor: 6.447

7.  Changes in plasma drug binding and alpha 1-acid glycoprotein in mother and newborn infant.

Authors:  M Wood; A J Wood
Journal:  Clin Pharmacol Ther       Date:  1981-04       Impact factor: 6.875

8.  Lithium and pregnancy. II. Hazards to women given lithium during pregnancy and delivery.

Authors:  M Schou; A Amdisen; O R Steenstrup
Journal:  Br Med J       Date:  1973-04-21

9.  Metabolism of metoprolol in the rat in vitro and in vivo.

Authors:  A Arfwidsson; K O Borg; K J Hoffmann; I Skånberg
Journal:  Xenobiotica       Date:  1976-11       Impact factor: 1.908

10.  Plasma anticonvulsant concentrations during pregnancy.

Authors:  C M Lander; V E Edwards; M J Eadie; J H Tyrer
Journal:  Neurology       Date:  1977-02       Impact factor: 9.910

View more
  20 in total

1.  Anatomical, physiological and metabolic changes with gestational age during normal pregnancy: a database for parameters required in physiologically based pharmacokinetic modelling.

Authors:  Khaled Abduljalil; Penny Furness; Trevor N Johnson; Amin Rostami-Hodjegan; Hora Soltani
Journal:  Clin Pharmacokinet       Date:  2012-06-01       Impact factor: 6.447

Review 2.  The treatment of hypertension in pregnancy. Clinical pharmacokinetic considerations.

Authors:  C Knott
Journal:  Clin Pharmacokinet       Date:  1991-10       Impact factor: 6.447

Review 3.  Clinical significance of pharmacokinetic models of hepatic elimination.

Authors:  D J Morgan; R A Smallwood
Journal:  Clin Pharmacokinet       Date:  1990-01       Impact factor: 6.447

Review 4.  Transcriptional Regulation of CYP2D6 Expression.

Authors:  Xian Pan; Miaoran Ning; Hyunyoung Jeong
Journal:  Drug Metab Dispos       Date:  2016-10-03       Impact factor: 3.922

Review 5.  Metoprolol: a pharmacoeconomic and quality-of-life evaluation of its use in hypertension, post-myocardial infarction and dilated cardiomyopathy.

Authors:  D H Peters; P Benfield
Journal:  Pharmacoeconomics       Date:  1994-10       Impact factor: 4.981

6.  Comparison of the pharmacokinetics of cephradine and cefazolin in pregnant and non-pregnant women.

Authors:  A Philipson; G Stiernstedt; M Ehrnebo
Journal:  Clin Pharmacokinet       Date:  1987-02       Impact factor: 6.447

7.  Pharmacokinetics of metoprolol during pregnancy and lactation.

Authors:  Rachel J Ryu; Sara Eyal; Thomas R Easterling; Steve N Caritis; Raman Venkataraman; Gary Hankins; Erik Rytting; Kenneth Thummel; Edward J Kelly; Linda Risler; Brian Phillips; Matthew T Honaker; Danny D Shen; Mary F Hebert
Journal:  J Clin Pharmacol       Date:  2015-12-04       Impact factor: 3.126

Review 8.  Pregnancy- Associated Changes in Pharmacokinetics and their Clinical Implications.

Authors:  Gideon Koren; Gali Pariente
Journal:  Pharm Res       Date:  2018-02-12       Impact factor: 4.200

9.  Hepatic Cyp2d and Cyp26a1 mRNAs and activities are increased during mouse pregnancy.

Authors:  Ariel R Topletz; Huong N Le; Nora Lee; John D Chapman; Edward J Kelly; Joanne Wang; Nina Isoherranen
Journal:  Drug Metab Dispos       Date:  2012-11-13       Impact factor: 3.922

Review 10.  Effect of pregnancy on the pharmacokinetics of antihypertensive drugs.

Authors:  Gail D Anderson; Darcy B Carr
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.